PA-TU-8988S

Cat.No.: CSC-C0326

Species: Human

Source: pancreas adenocarcinoma

Morphology: adherent epitheloid cells growing in monolayers

Culture Properties: monolayer

Datasheet

Inquire for Price

Specification
Q & A
Customer Review
Publications

Cat.No.

CSC-C0326

Description

Established in 1985 from the liver metastasis of a primary pancreatic adenocarcinoma from a 64-year-old woman (sister cell line is PA-TU-8988T)

Species

Human

Source

pancreas adenocarcinoma

Recommended Medium

90% DMEM + 5%h.i. FBS + 5%horse serum

Culture Properties

monolayer

Morphology

adherent epitheloid cells growing in monolayers

Karyotype

Human near triploid karyotype with 6% polyploidy - 71(67-77)<3n>XXX, +3, -4, +7, -8, +9, +11, +11, -15, -17, -18, -18, -19, -21, -22, +6mar, del(1)(p21), del(3)(p11p22), del(6)(q26), del(9)(p12), dup(11)(p14->pter), del(12)(p13), add (15)(p12)

Quality Control

Mycoplasma: negative in DAPI, microbiological culture, RNA hybridization, PCR assays
Immunology: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -,

Storage and Shipping

Frozen with 70% medium, 20% FBS, 10% DMSO at about 3 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen

Citation Guidance

If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Are there any alternatives to Ham's F12 medium?

Yes, there are several other cell culture media available that can be used as alternatives to Ham's F12 medium, such as Dulbecco's modified eagle medium (DMEM) or RPMI-1640. The choice of medium depends on the specific requirements of the cell line and the experiment being conducted.

Ask a Question

Average Rating: 5.0 | 1 Scientist has reviewed this product

Additional support

Creative Bioarray provides additional support, such as technical consultations or webinars, which can be beneficial for researchers aiming to maximize the value and utility of the tumor cell product, especially in relation to affordability.

21 Aug 2023

Ease of use
After sales services
Value for money

Write your own review

You May Also Need

CM-1010X

CS-001Y

CS-006Y

PremSera® Horse Serum-New Zealand Origin

INQUIRY

PA-TU-8988T

Description: Established in 1985 from the liver metastasis of a primary pancreatic adenocarcinoma from a 64-year-old woman; sister cell line of PA-TU-8988S

Cat#: CSC-C0307 INQUIRY

View Product

PA-TU-8902

Description: Established in 1985 from the primary ductal pancreatic adenocarcinoma (grade II) from a 44-year-old woman; reported as inducing metastasis in nude mice and as secreting proteinases (e.g. urokinase, cathepsin B and D)

Cat#: CSC-C0312 INQUIRY

View Product

HUP-T4

Description: Established from the malignant ascites of a 60-year-old Japanese man with pancreas carcinoma in 1985

Cat#: CSC-C0333 INQUIRY

View Product

HUP-T3

Description: Established from the malignant ascites of a 66-year-old Japanese man with pancreas carcinoma in 1984

Cat#: CSC-C0359 INQUIRY

View Product

YAPC

Description: Established from ascites obtained during exploratory laparatomy of a 43-year-old Japanese man with pancreas carcinoma (terminal, no therapy) in December 1993; cells were described as being dependent on autocrinely secreted IL-1alpha

Cat#: CSC-C0430 INQUIRY

View Product

KCI-MOH1

Description: Originally described to be derived from the moderately differentiated adenocarcinoma of the head of the pancreas from a 74-year-old African-American man in 1996; patient was treated with pancreato-duodenectomy; cells were described as being tumorigenic in SCID mice; however, DNA fingerprinting and cytogenetic analysis showed cross-contamination with cell line HPAC which was established in 1985 from the pancreas adenocarcinoma of a 64-year-old Caucasian woman

Cat#: CSC-C0509 INQUIRY

View Product

For research use only. Not for any other purpose.